Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study
暂无分享,去创建一个
A. Avallone | Giorgio Reggiardo | G. Aprile | G. D. Lucca | R. Bordonaro | G. Rosati | S. Cordio | A. Butera | H. S. Parra | F. D. Pauli